SI2662093T1 - Formulacija tobramicina - Google Patents

Formulacija tobramicina

Info

Publication number
SI2662093T1
SI2662093T1 SI201330018T SI201330018T SI2662093T1 SI 2662093 T1 SI2662093 T1 SI 2662093T1 SI 201330018 T SI201330018 T SI 201330018T SI 201330018 T SI201330018 T SI 201330018T SI 2662093 T1 SI2662093 T1 SI 2662093T1
Authority
SI
Slovenia
Prior art keywords
tobramycin formulation
tobramycin
formulation
Prior art date
Application number
SI201330018T
Other languages
English (en)
Inventor
David Higham
Kevin Hawkins
Original Assignee
Norton Healthcare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norton Healthcare Limited filed Critical Norton Healthcare Limited
Priority claimed from EP13002039.9A external-priority patent/EP2662093B1/en
Publication of SI2662093T1 publication Critical patent/SI2662093T1/sl

Links

SI201330018T 2012-05-09 2013-04-18 Formulacija tobramicina SI2662093T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261644700P 2012-05-09 2012-05-09
EP13002039.9A EP2662093B1 (en) 2012-05-09 2013-04-18 Tobramycin formulation

Publications (1)

Publication Number Publication Date
SI2662093T1 true SI2662093T1 (sl) 2015-06-30

Family

ID=52594985

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201330018T SI2662093T1 (sl) 2012-05-09 2013-04-18 Formulacija tobramicina

Country Status (5)

Country Link
CY (1) CY1116053T1 (sl)
ES (1) ES2530751T3 (sl)
HR (1) HRP20150085T1 (sl)
RS (1) RS53878B1 (sl)
SI (1) SI2662093T1 (sl)

Also Published As

Publication number Publication date
ES2530751T3 (es) 2015-03-05
CY1116053T1 (el) 2017-02-08
RS53878B1 (en) 2015-08-31
HRP20150085T1 (hr) 2015-05-08

Similar Documents

Publication Publication Date Title
HK1203146A1 (en) Antibody formulation
PL2802209T3 (pl) Preparaty do uszu
GB201217441D0 (en) Composition
GB201200707D0 (en) Composition
HK1202445A1 (en) New formulation
ZA201306000B (en) Stable formulation
GB201218954D0 (en) Composition
EP2878295A4 (en) COMPOSITION
PT2662093E (pt) Formulação de tobramicina
EP2837670A4 (en) COMPOSITION CONTAINING FLUOROBIPHENYL
GB201206035D0 (en) Composition
EP2910537A4 (en) AGENT COMPOSITION GENERATING GAS
EP2910538A4 (en) AGENT COMPOSITION GENERATING GAS
GB201209597D0 (en) Composition
GB201208133D0 (en) Composition
HK1206989A1 (en) Encapsulated formulation
GB201219383D0 (en) Composition
GB201218195D0 (en) Composition
SI2662093T1 (sl) Formulacija tobramicina
GB201211247D0 (en) Improved formulation
GB201220595D0 (en) Keysafe application
AU2012905439A0 (en) Formulation
AU2012905410A0 (en) Formulation
GB201222922D0 (en) Topical formulation
GB201219065D0 (en) Composition